Shares of Inari Medical, Inc. (NASDAQ:NARI – Get Rating) have earned a consensus recommendation of “Buy” from the nine brokerages that are presently covering the firm, MarketBeat Ratings reports. Seven equities research analysts have rated the stock with a buy recommendation. The average 1 year target price among brokerages that have updated their coverage on […]
Texas Permanent School Fund lowered its stake in Inari Medical, Inc. (NASDAQ:NARI – Get Rating) by 6.1% during the fourth quarter, Holdings Channel.com reports. The fund owned 32,463 shares of the company’s stock after selling 2,098 shares during the quarter. Texas Permanent School Fund’s holdings in Inari Medical were worth $2,063,000 at the end of […]
Inari Medical (NASDAQ:NARI – Get Rating) issued its earnings results on Wednesday. The company reported ($0.04) EPS for the quarter, topping the consensus estimate of ($0.23) by $0.19, Briefing.com reports. Inari Medical had a negative net margin of 6.87% and a negative return on equity of 6.78%. The company had revenue of $116.17 million for […]
Inari Medical (NASDAQ:NARI – Get Rating) and Stryker (NYSE:SYK – Get Rating) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their institutional ownership, risk, dividends, valuation, earnings, analyst recommendations and profitability. Analyst Ratings This is a summary of recent recommendations for Inari […]